Monday December 18th 2017

The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) Trial (P3.191)

CONCLUSIONS: The VIDAMS trial will provide critical information about the safety and efficacy of vitamin D therapy in RRMS. Establishing the utility of vitamin D supplementation will have implications for the treatment of MS patients worldwide.Study Supported by: National MS Society (RG 4407A2)Disclosure: Dr. Bhargava has nothing to disclose. Dr. Steele has nothing to disclose. Dr. Cassard has nothing to disclose. Dr. Sugar has nothing to disclose. Dr. Pelletier has received personal compensation for activities with Teva Neuroscience, Genentech Inc., Biogen Idec as a speaker and advisory board member, and activities with Bayer Pharmaceuticals Corp. and Synarc as a consultant. Dr. Pelletier has received research support from Biogen Idec. Dr. Waubant has received personal compensation for ac…

View original¬†–¬†

The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) Trial (P3.191)

Leave a Comment

More from category

MS Activists Celebrate 2017 State Policy Impact
MS Activists Celebrate 2017 State Policy Impact

/About-the-Society/News/MS-Activists-Celebrate-2017-State-Policy-Impact [Read More]

MS Research Program Funding Authorized by President Trump
MS Research Program Funding Authorized by President Trump

/About-the-Society/News/MS-Research-Program-Funding-Authorized-by-Presiden [Read More]

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]